跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Flosazin
Approved
STANDARD
Flosazin
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2c84908dfb5edfb1
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
2c84908dfb5edfb1
Drug Approval Philippines Name
Flosazin
Product Name
Flosazin
Registration Number
DRP-15483-02
Brand Name
Flosazin
Generic Name
Dapagliflozin (as propanediol monohydrate)
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Asterzenmed Inc.
Issuance Date
24 September 2024
Expiry Date
16 July 2029
Pharmacologic Category
Blood glucose lowering drug [Sodium-glucose co-transporter 2(SGLT2) Inhibitor]
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2c84908dfb5edfb1
Type
Standard
Back to Philippines FDA Approvals
Flosazin - Philippines FDA Drug Approval Details